Welcure Drugs & Pharmaceuticals Ltd.

WELCURE DRUG

Market Cap
₹6 Cr.
P/E
571.19

Welcure Drugs & Pharmaceuticals Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income component is making ratios of the company look optically better
Pledge
Promoters have not pledged a significant portion of their holding
Capex vs ROCE
Unable to calculate due to limited data
Revenue Recognition
Unable to calculate due to limited data
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years due to earnings
ROE
Asset Turnover is responsible for ROE increase over last 10 years
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Unable to calculate due to limited data
Promoter Holding
Promoter has not sold any shares in the last 90 days
ROE
Latest
6.71%
3yr Average
37.17%
5yr Average
12.43%
Net Profit Margin
Latest
None%
3yr Average
21.27%
5yr Average
11.46%
ROCE
Latest
6.72%
3yr Average
37.24%
5yr Average
12.68%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Revenue mix

Product Wise Break-Up

Latest
|
locked
Historic
Show more
Company Filing
Show Previous Years
Discussions & Analysis
timeline